Hollings Cancer Center, MUSC is a clinical research site located in Charleston, South Carolina, United States 29425.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Hollings Cancer Center, MUSC has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Solid Tumor Malignancies, Brain Metastases From Solid Tumors, Endometrial Cancer.
Sponsors: A2A Pharmaceuticals Inc., AEterna Zentaris.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in South Carolina · View every site in Charleston
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hollings Cancer Center, MUSC has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hollings Cancer Center, MUSC has 2 clinical trials on record, with 1 currently active. Their work covers Solid Tumor Malignancies, Brain Metastases From Solid Tumors, Endometrial Cancer.
Hollings Cancer Center, MUSC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.